Trial intelligence / Profile preview

ICG fluorescence bronchoscopy for tracheal anastomotic perfusion

2013-001725-10Phase 2Completed

Sponsor
Medical University of Vienna
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of indocyanine green in tracheal stenosis (TS), sponsored by Medical University of Vienna. Primary endpoints: Measurable ICG fluorescence intraoperative at anastomotic site, Measurable ICG fluorescence 3–5 days postoperative at anastomotic site and 1 more. Started Dec 2013; status: completed.

02

Drugs

indocyanine green
03

Conditions

tracheal stenosis (TS)

Beyond the preview

Go deeper on 2013-001725-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001725-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call